Year 2009 - Year 2008 - Year 2007 - Year 2006 - Year 2004 - Year 2003 - Year 2002
Trophos starts Phase Ib Clinical Trial of TRO19622 in Spinal Muscular Atrophy
Trophos Closes € 8.5 Million in Series C Funding
Trophos describes identification, characterization
and broad neuroprotective properties of TRO19622
in Journal of Pharmacology and Experimental
Therapeutics
Trophos starts Phase II Clinical Trial of TRO19622
in painful diabetic neuropathy
Trophos successfully completes Phase Ib ALS clinical trials for TRO19622, a novel compound to treat neurodegenerative disease
Trophos SA and CHDI, Inc. extend partnership to develop promising compounds in models relevant to Huntington disease
Trophos Granted Orphan Drug Status for TRO19622 for the treatment of Amyotrophic Lateral Sclerosis in Europe
Trophos will start Phase II clinical trial in diabetic neuropathy after successful completion of preclinical studies
Trophos Appoints Jacques Essinger as President of Supervisory Board
Trophos to present at American Academy of Neurology meeting
Trophos strengthens management team with key appointments
Trophos successfully completes phase I clinical trials for novel compound to treat neurodegenerative diseases
Trophos initates phase 1 clinical trial with TRO19622
Trophos appoints Jean-Louis Abitbol as director of clinical development
Trophos renews its collaborative agreement with the AFM
Trophos raises 6.4 M €
Dr. Rebecca Pruss appointed as CSO
Health Minister Jean-François Mattei inaugures Trophos' new facilities